EP
Eversept Partners Portfolio holdings
AUM
$1.52B
1-Year Est. Return
121.13%
This Fund
S&P 500
1 Year Est. Return
+121.13%
AUM
$1.78B
AUM Growth
+$478M
(+37%)
Holding
122
Top Buys
| 1 | +$27.7M | |
| 2 | +$26.1M | |
| 3 | +$25.2M | |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$19.4M |
| 5 |
Danaher
DHR
|
+$19.1M |
Top Sells
| 1 | +$39.4M | |
| 2 | +$38.6M | |
| 3 | +$31.4M | |
| 4 |
Revvity
RVTY
|
+$22.2M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$17.3M |
Sector Composition
| 1 | Healthcare | 99.91% |
| 2 | Financials | 0.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Liquidia Corp
LQDA
$5.56B
| $17.6M | 0.99% |
509,443
+23,422
|
|
||
27
Icon
ICLR
$11.7B
| $17.5M | 0.98% |
95,832
+40,807
|
|
||
28
HealthEquity
HQY
$7.19B
| $17M | 0.95% |
185,739
+133,351
|
|
||
29
Glaukos
GKOS
$7.15B
| $16.7M | 0.93% |
+147,471
|
|
||
|
30
Revvity
RVTY
$11.4B
| $15.7M | 0.88% |
162,777
-231,534
|
|
||
31
NewAmsterdam Pharma
NAMS
$3.82B
| $14.8M | 0.83% |
420,827
-67,765
|
|
||
32
Esperion Therapeutics
ESPR
$806M
| $14.2M | 0.8% |
+3,851,133
|
|
||
33
Biogen
BIIB
$29B
| $13.7M | 0.77% |
77,944
+26,179
|
|
||
34
Select Medical
SEM
$2.04B
| $13.5M | 0.75% |
+906,100
|
|
||
35
Centene
CNC
$31B
| $13.3M | 0.75% |
324,092
+99,542
|
|
||
36
CG Oncology
CGON
$4.95B
| $12.8M | 0.72% |
+308,466
|
|
||
37
Bristol-Myers Squibb
BMY
$116B
| $12.7M | 0.71% |
+235,293
|
|
||
38
Palisade Bio
PALI
$335M
| $12.7M | 0.71% |
+5,391,548
|
|
||
39
Arcutis Biotherapeutics
ARQT
$2.75B
| $12.6M | 0.71% |
434,634
+323,168
|
|
||
40
Pharvaris
PHVS
$2.21B
| $12.2M | 0.68% |
+439,177
|
|
||
41
Eli Lilly
LLY
$1T
| $11.4M | 0.64% |
+10,623
|
|
||
42
Encompass Health
EHC
$9.9B
| $11.3M | 0.64% |
+106,926
|
|
||
43
CytomX Therapeutics
CTMX
$692M
| $10.7M | 0.6% |
+2,507,090
|
|
||
44
Elevance Health
ELV
$88.9B
| $10.6M | 0.59% |
30,195
-14,785
|
|
||
45
MannKind Corp
MNKD
$1.09B
| $10.5M | 0.59% |
1,852,563
-190,164
|
|
||
46
Xenon Pharmaceuticals
XENE
$5.12B
| $10.4M | 0.58% |
+231,380
|
|
||
47
Ascendis Pharma A/S
ASND
$13.5B
| $10.3M | 0.58% |
+48,241
|
|
||
48
Intuitive Surgical
ISRG
$148B
| $10.2M | 0.57% |
18,062
+3,636
|
|
||
49
Illumina
ILMN
$25.4B
| $10.1M | 0.56% |
76,721
-46,953
|
|
||
50
Ardelyx
ARDX
$1.33B
| $10M | 0.56% |
1,715,129
+285,752
|
|